Jeff Cislini Revolution Medicines, Inc. (RVMD) insider trading activity

RVMD Quotes by TradingView

Jeff Cislini is General Counsel of Revolution Medicines, Inc.. Currently has a direct ownership of 41,628 shares of RVMD, which is worth approximately $1.89 Million. The most recent transaction as insider was on Dec 16, 2024, when has been sold 1,599 shares (Common Stock) at a price of $45.4 per share, resulting in proceeds of $72,594. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.6K
8.78% 3M change
11.65% 12M change
Total Value Held $1.89 Million

Jeff Cislini Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2024
SELL
Open market or private sale
$72,594 $45.4 p/Share
1,599 Reduced 3.7%
41,628 Common Stock
Nov 15 2024
SELL
Open market or private sale
$140,802 $55.13 p/Share
2,554 Reduced 5.6%
43,080 Common Stock
Nov 06 2024
SELL
Open market or private sale
$360,000 $60.0 p/Share
6,000 Reduced 11.62%
45,634 Common Stock
Nov 06 2024
BUY
Exercise of conversion of derivative security
$219,420 $36.57 p/Share
6,000 Added 10.41%
51,634 Common Stock
Oct 11 2024
SELL
Open market or private sale
$301,020 $50.17 p/Share
6,000 Reduced 11.62%
45,634 Common Stock
Oct 11 2024
BUY
Exercise of conversion of derivative security
$219,420 $36.57 p/Share
6,000 Added 10.41%
51,634 Common Stock
Sep 16 2024
SELL
Open market or private sale
$64,252 $44.19 p/Share
1,454 Reduced 3.09%
45,634 Common Stock
Jul 09 2024
SELL
Open market or private sale
$97,951 $40.83 p/Share
2,399 Reduced 4.85%
47,088 Common Stock
Jun 26 2024
SELL
Open market or private sale
$76,940 $38.47 p/Share
2,000 Reduced 3.88%
49,487 Common Stock
Jun 17 2024
SELL
Open market or private sale
$65,694 $37.39 p/Share
1,757 Reduced 3.3%
51,487 Common Stock
May 21 2024
SELL
Open market or private sale
$58,635 $39.09 p/Share
1,500 Reduced 2.76%
52,874 Common Stock
Mar 27 2024
SELL
Open market or private sale
$46,425 $30.95 p/Share
1,500 Reduced 2.68%
54,374 Common Stock
Mar 18 2024
SELL
Open market or private sale
$39,538 $31.58 p/Share
1,252 Reduced 2.19%
55,874 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
21,000 Added 26.88%
57,126 Common Stock
Jan 22 2024
SELL
Open market or private sale
$40,500 $27.0 p/Share
1,500 Reduced 3.99%
36,126 Common Stock
Dec 18 2023
SELL
Open market or private sale
$31,831 $25.9 p/Share
1,229 Reduced 3.19%
37,284 Common Stock
Nov 20 2023
SELL
Open market or private sale
$32,550 $21.7 p/Share
1,500 Reduced 3.75%
38,513 Common Stock
Sep 28 2023
SELL
Open market or private sale
$57,160 $28.58 p/Share
2,000 Reduced 4.76%
40,013 Common Stock
Sep 18 2023
SELL
Open market or private sale
$38,010 $31.31 p/Share
1,214 Reduced 2.81%
42,013 Common Stock
Jul 31 2023
SELL
Open market or private sale
$39,030 $26.02 p/Share
1,500 Reduced 3.35%
43,227 Common Stock
Jun 20 2023
SELL
Open market or private sale
$31,148 $25.14 p/Share
1,239 Reduced 2.7%
44,727 Common Stock
JC

Jeff Cislini

General Counsel
Redwood City, CA

Track Institutional and Insider Activities on RVMD

Follow Revolution Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

News

Receive news related to Revolution Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RVMD